Cargando…

Poorly differentiated thyroid carcinoma: a clinician’s perspective

Poorly differentiated thyroid carcinoma (PDTC) is a rare thyroid carcinoma originating from follicular epithelial cells. No explicit consensus can be achieved to date due to sparse clinical data, potentially compromising the outcomes of patients. In this comprehensive review from a clinician’s persp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tong, Junyu, Ruan, Maomei, Jin, Yuchen, Fu, Hao, Cheng, Lin, Luo, Qiong, Liu, Zhiyan, Lv, Zhongwei, Chen, Libo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010806/ https://www.ncbi.nlm.nih.gov/pubmed/35195082 http://dx.doi.org/10.1530/ETJ-22-0021

Ejemplares similares

(99m)Tc-pertechnetate-avid metastases from differentiated thyroid cancer are prone to benefit from (131)I therapy: A prospective observational study
por: Liu, Min, et al.
Publicado: (2017)

RECIST 1.1 and serum thyroglobulin measurements in the evaluation of responses to sorafenib in patients with radioactive iodine-refractory differentiated thyroid carcinoma
por: RUAN, MAOMEI, et al.
Publicado: (2013)

Predicting (131)I-avidity of metastases from differentiated thyroid cancer using (18)F-FDG PET/CT in postoperative patients with elevated thyroglobulin
por: Liu, Min, et al.
Publicado: (2018)

HER inhibitor promotes BRAF/MEK inhibitor-induced redifferentiation in papillary thyroid cancer harboring BRAFV600E
por: Cheng, Lingxiao, et al.
Publicado: (2017)

Gut microbiota changes and its potential relations with thyroid carcinoma
por: Yu, Xiaqing, et al.
Publicado: (2021)

Initial or salvage treatment with apatinib shows promise against radioiodine-refractory differentiated thyroid carcinoma
por: Qiu, Xian, et al.
Publicado: (2022)

Comparison of Clinical and Ultrasonographic Features of Poorly Differentiated Thyroid Carcinoma and Papillary Thyroid Carcinoma
por: Zhang, Bo, et al.
Publicado: (2016)

Anxiety and depression status prior to radioactive iodine therapy among differentiated thyroid cancer patients during the COVID‑19 pandemic
por: Qiao, Tingting, et al.
Publicado: (2022)

Poorly Differentiated Thyroid Carcinoma: An Incubating Entity
por: Sadow, Peter M., et al.
Publicado: (2012)

Poorly differentiated thyroid carcinoma: An underdiagnosed entity
por: Dettmer, M. S., et al.
Publicado: (2019)

Poorly differentiated thyroid carcinoma: An institutional experience
por: Choi, Seok Won, et al.
Publicado: (2020)

Initial Therapy of Advanced Anaplastic Thyroid Cancer via Targeting VEGFR-2: A Case Report
por: Cheng, Lin, et al.
Publicado: (2019)

Increased (18)F-FDG uptake of heterotopic pancreatitis in the small intestine: A CARE-compliant case report
por: Ruan, Maomei, et al.
Publicado: (2016)

DNA Methylation Age Drift Is Associated with Poor Outcomes and De-Differentiation in Papillary and Follicular Thyroid Carcinomas
por: Liu, Tiantian, et al.
Publicado: (2021)

CCL22 and CCL26 are potential biomarkers for predicting distant metastasis in thyroid carcinoma
por: Tong, Junyu, et al.
Publicado: (2022)

Distinguishing Patients With Distant Metastatic Differentiated Thyroid Cancer Who Biochemically Benefit From Next Radioiodine Treatment
por: Sa, Ri, et al.
Publicado: (2020)

Genetic Alterations in Poorly Differentiated and Undifferentiated Thyroid Carcinomas
por: Soares, Paula, et al.
Publicado: (2011)

Poorly Differentiated Thyroid Carcinoma Arising in Struma Ovarii
por: Khunamornpong, Surapan, et al.
Publicado: (2015)

Outcomes of lenvatinib therapy in poorly differentiated thyroid carcinoma
por: Roque, João, et al.
Publicado: (2023)

An Unexpected Finding of Poorly Differentiated Thyroid Carcinoma in a Toxic Thyroid Nodule
por: Yuang, Kimberly, et al.
Publicado: (2023)

Postoperative radioiodine therapy impact on survival in poorly differentiated thyroid carcinoma: a population-based study
por: Xu, Lei, et al.
Publicado: (2021)

Alterations of Gut Microbiome and Metabolite Profiles Associated With Anabatic Lipid Dysmetabolism in Thyroid Cancer
por: Lu, Ganghua, et al.
Publicado: (2022)

Differential diagnostic value of the ResNet50, random forest, and DS ensemble models for papillary thyroid carcinoma and other thyroid nodules
por: Deng, Chengwen, et al.
Publicado: (2022)

Combined tazemetostat and MAPKi enhances differentiation of papillary thyroid cancer cells harbouring BRAF (V600E) by synergistically decreasing global trimethylation of H3K27
por: Fu, Hao, et al.
Publicado: (2020)

Analysis of Clinical Outcome of Patients with Poorly Differentiated Thyroid Carcinoma
por: Tanaka, Katsuhiro, et al.
Publicado: (2011)

Poorly differentiated carcinoma of the thyroid retrospective clinical and morphologic evaluation.
por: Hwang, T. S., et al.
Publicado: (1990)

Poorly differentiated thyroid carcinoma: a retrospective clinicopathological study
por: Cherkaoui, Ghofrane Salhi, et al.
Publicado: (2015)

Contribution of cytologic examination to diagnosis of poorly differentiated thyroid carcinoma
por: Kim, Na Rae, et al.
Publicado: (2020)

Hobnail variant of papillary thyroid carcinoma: molecular profiling and comparison to classical papillary thyroid carcinoma, poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma
por: Teng, Lianghong, et al.
Publicado: (2017)

Contrast-enhanced CT-based Radiomics for the Differentiation of Anaplastic or Poorly Differentiated Thyroid Carcinoma from Differentiated Thyroid Carcinoma: A Pilot Study
por: Moon, Jayoung, et al.
Publicado: (2023)

Poorly differentiated ("insular") carcinoma of the thyroid gland--two cases report.
por: Paik, S. S., et al.
Publicado: (1997)

Gene expression profiling associated with the progression to poorly differentiated thyroid carcinomas
por: Pita, J M, et al.
Publicado: (2009)

Application of intensity-modulated radiotherapy in unresectable poorly differentiated thyroid carcinoma
por: Xue, Fen, et al.
Publicado: (2016)

MON-452 Poorly Differentiated Thyroid Carcinoma Metastatic to the Adrenal Gland
por: Mathias, Priyanka, et al.
Publicado: (2020)

Course of Disease and Clinical Management of Patients with Poorly Differentiated Thyroid Carcinoma
por: Grawe, Freba, et al.
Publicado: (2021)

Poorly Differentiated Thyroid Carcinoma: Single Centre Experience and Review of the Literature
por: Bellini, Maria Irene, et al.
Publicado: (2021)

Case Report: Implantation of Dedifferentiated to Poorly Differentiated Thyroid Carcinoma After Endoscopic Thyroid Surgery
por: Hu, Jin, et al.
Publicado: (2022)

The reliability and validity of the training elements scale for clinicians in the new era——based on the perspective of Chinese doctors’ job demands
por: Jin, Weiqiong, et al.
Publicado: (2023)

Successful pregnancy without disease progression of radioiodine refractory papillary thyroid carcinoma: a case report
por: Jin, Yuchen, et al.
Publicado: (2017)

Poorly differentiated adenocarcinoma of an unknown primary with a thyroid tumour and an aggressive course: thyroid or lung carcinoma?
por: Ito, Toshiki, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hp90memmkpk2fbatsbm1p9f7f0